Oramed Pharmaceuticals News

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Reznick Yehuda

Apr 18 20:12 ET

Oramed Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Reznick Yehuda

Apr 2 17:31 ET

Oramed Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Nadav Kidron(5.7%)

Mar 22 21:33 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aghion Daniel

Jan 30 17:33 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kidron Miriam

Jan 8 00:00 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer KIDRON NADAV

Jan 8 00:00 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hexter Joshua

Jan 8 00:00 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Mayer Arie

Jan 8 00:00 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Rozov Yadin

Jan 8 00:00 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sank Leonard

Jan 8 00:00 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Silberman David

Jan 8 00:00 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Shapiro Benjamin

Jan 8 00:00 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aghion Daniel

Jan 8 00:00 ET

Oramed Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Aghion Daniel

Jan 2 00:00 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer KIDRON NADAV

May 31, 2023 17:10 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kidron Miriam

May 31, 2023 17:10 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Derovan Netanel

May 31, 2023 17:10 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hexter Joshua

May 31, 2023 17:10 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Silberman David

May 31, 2023 17:10 ET

Oramed Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Shapiro Benjamin

May 1, 2023 17:12 ET